We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+5.45%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$819M
AUM Growth
+$123M
(+18%)
Cap. Flow
+$101M
Cap. Flow
% of AUM
12.29%
Top 10 Holdings %
Top 10 Hldgs %
9.75%
Holding
710
New
168
Increased
162
Reduced
95
Closed
285
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$9.74M |
| 2 |
McDonald's
MCD
|
+$8.2M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$8.03M |
| 4 |
AGN
Allergan plc
AGN
|
+$7.37M |
| 5 |
Henry Schein
HSIC
|
+$6.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$7.17M |
| 2 |
Lam Research
LRCX
|
+$6.99M |
| 3 |
Electronic Arts
EA
|
+$6.98M |
| 4 |
MBLY
Mobileye N.V.
MBLY
|
+$6.79M |
| 5 |
Hilton Worldwide
HLT
|
+$6.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.19% |
| 2 | Technology | 15.05% |
| 3 | Consumer Discretionary | 14.44% |
| 4 | Financials | 11.43% |
| 5 | Consumer Staples | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Baidu
BIDU
$35.7B
| – | – |
-7,411
| Closed | -$1.33M |
|
452
Biogen
BIIB
$30.4B
| – | – |
-4,900
| Closed | -$1.33M |
|
453
Bloomin' Brands
BLMN
$736M
| – | – |
-6,100
| Closed | -$130K |
|
454
Box
BOX
$4.36B
| – | – |
-1,300
| Closed | -$24K |
|
455
Boston Scientific
BSX
$68.5B
| – | – |
-28,391
| Closed | -$787K |
|
456
British American Tobacco
BTI
$134B
| – | – |
-1
| Closed | – |
|
457
AB InBev
BUD
$161B
| – | – |
-10,700
| Closed | -$1.18M |
|
458
BWX Technologies
BWXT
$15.5B
| – | – |
-22,400
| Closed | -$1.09M |
|
|
BZUN
459
Baozun
BZUN
$168M
| – | – |
-172
| Closed | -$4K |
|
460
Credit Acceptance
CACC
$5.84B
| – | – |
-32
| Closed | -$8K |
|
461
Cheesecake Factory
CAKE
$4.42B
| – | – |
-19,351
| Closed | -$973K |
|
462
CBRE Group
CBRE
$43.1B
| – | – |
-4,009
| Closed | -$146K |
|
463
Cabot Corp
CBT
$4.7B
| – | – |
-1,100
| Closed | -$59K |
|
464
CDW
CDW
$18.4B
| – | – |
-12,700
| Closed | -$794K |
|
465
Celanese
CE
$4.77B
| – | – |
-3,740
| Closed | -$355K |
|
466
Century Aluminum
CENX
$4.35B
| – | – |
-1,200
| Closed | -$19K |
|
467
Citizens Financial Group
CFG
$30.8B
| – | – |
-23,602
| Closed | -$842K |
|
468
Cullen/Frost Bankers
CFR
$10.5B
| – | – |
-800
| Closed | -$75K |
|
469
Church & Dwight Co
CHD
$23.7B
| – | – |
-1,500
| Closed | -$78K |
|
470
Charter Communications
CHTR
$16.7B
| – | – |
-400
| Closed | -$135K |
|
471
Cigna
CI
$79.6B
| – | – |
-27,200
| Closed | -$4.55M |
|
472
Ciena
CIEN
$49.6B
| – | – |
-79,565
| Closed | -$1.99M |
|
473
Cincinnati Financial
CINF
$28.3B
| – | – |
-1,400
| Closed | -$101K |
|
474
Core Laboratories
CLB
$493M
| – | – |
-701
| Closed | -$71K |
|
475
Clorox
CLX
$12.1B
| – | – |
-2,805
| Closed | -$374K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2017 Portfolio in Review
As of Q3 2017, Seven Eight Capital held 710 positions worth $819M, up 18% from $696M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Seven Eight Capital deployed $101M of net new capital in Q3 2017, opening 168 new positions and adding to 162 existing holdings. Its largest new stake was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Constellation Brands, an estimated $6.37M trimmed.
- Seven Eight Capital's largest Q3 2017 buy was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.
- Seven Eight Capital added most to McDonald's in Q3 2017, an estimated $8.2M increase.
- Seven Eight Capital's biggest Q3 2017 reduction was Constellation Brands, cutting an estimated $6.37M.
- Seven Eight Capital fully exited Nike in Q3 2017, selling an estimated $7.17M.
- Seven Eight Capital's ten largest holdings make up 9.8% of its $819M portfolio in Q3 2017.
- Seven Eight Capital opened 168 new positions and closed 285 in Q3 2017.
- Seven Eight Capital's portfolio value rose 18% quarter-over-quarter to $819M.
Based on Seven Eight Capital's 13F filing for Q3 2017, filed 16 Oct 2017.